AMPE - Ampio moves forward with Ampion protocol June, 14 2019 07:40 AM Ampio Pharmaceuticals Inc. Ampio Pharmaceuticals (NYSEMKT:AMPE) announces that it landed FDA approval of its special protocol assessment of a clinical protocol.More news on: Ampio Pharmaceuticals, Inc., Healthcare stocks news, Read more ...